Results 101 to 110 of about 27,191 (230)

Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli [PDF]

open access: gold, 2021
Su-Bin Hwang   +6 more
openalex   +1 more source

Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.

open access: yesJournal of Infectious Diseases, 2005
J. Brooks   +6 more
semanticscholar   +1 more source

Shiga Toxin–producing Escherichia coli, Idaho

open access: yesEmerging Infectious Diseases, 2007
Vivian Marie Lockary   +2 more
doaj   +1 more source

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

open access: yesNew England Journal of Medicine, 2011
C. Frank   +20 more
semanticscholar   +1 more source

MOESM1 of Draft genome sequence of non-shiga toxin-producing Escherichia coli O157 NCCP15738

open access: gold, 2016
Taesoo Kwon   +6 more
openalex   +1 more source

Primary Thrombotic Microangiopathy in Pediatric Patients

open access: yesGlobal Pediatric Health
Background . Primary thrombotic microangiopathy includes hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli , atypical hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Methodology .
Andrés David Aranzazu Ceballos MD   +5 more
doaj   +1 more source

Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis.

open access: yesFoodborne pathogens and disease, 2014
S. Majowicz   +7 more
semanticscholar   +1 more source

Persistent cross-species transmission systems dominate Shiga toxin-producingEscherichia coliO157:H7 epidemiology in a high incidence region: a genomic epidemiology study [PDF]

open access: green
Gillian A.M. Tarr   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy